Loading...
One-Minute Summary
> Key Conclusions:
> - Dry needling: economical, entry-level option; effective for short-term myofascial pain but more prone to relapse.
> - Dextrose prolotherapy: best for "chronic degeneration at musculotendinous junctions"; gentle collagen stimulation.
> - PRP: a 2022 RCT showed superior long-term outcomes vs dry needling for severe chronic myofascial pain, especially in patient satisfaction.
> - Clinical decision logic: depends on pain duration, severity, and presence of structural degeneration.
> - Common foundation: all three therapies outperform "pain medications without addressing the source."
What Is Myofascial Pain? Why Is It So Hard to Treat?
Myofascial pain syndrome (MPS) is one of the most common causes of chronic pain. Its hallmark is the "trigger point" — a tense knot within muscle that, when pressed:
• Hurts
• Refers pain to a distant area
• Elicits a local twitch response in specific muscles
Why is it hard to treat?
Multifactorial pathogenesis: ischemia, inflammation, neural sensitization, and postural imbalance all contribute
Chronification: untreated MPS develops "central sensitization," changing the pain system itself
Single-modality therapies are often insufficient: medications, rehabilitation, and massage each have limits
> Key insight: Chronic myofascial pain treatment requires precision intervention at the trigger point — this is the value of injection therapies.
Three Mainstream Injection Therapies
Therapy A: Dry Needling
Mechanism:
A fine needle (no injectate) penetrates the trigger point, eliciting a local twitch response that disrupts abnormal electrophysiological loops.
Strengths:
• Economical (no medication cost)
• Rapid effect on short-term myofascial pain
• Very few side effects
• Short procedure time
Limitations:
• Effects typically diminish after 1–3 months
• Limited efficacy for severe degeneration or structural problems
• "Treatment soreness" notable on day of and day after
Best Indications:
• Short-to-mid-term myofascial tension
• Upper back, neck-shoulder, low back trigger points
• Patients sensitive to medication side effects
• Budget considerations
Therapy B: Dextrose Prolotherapy
Mechanism:
Inject 12.5–25% dextrose solution at the trigger point and surrounding tendon/ligament insertions. Dextrose causes a mild inflammatory response, stimulating collagen synthesis and promoting repair of chronically degenerated tissue.
Strengths:
• Best for "chronic degeneration at musculotendinous junctions"
• Unique advantage for ligamentous laxity and chronic fascial pain
• Moderate cost
• Few side effects
Limitations:
• Slower onset (typically 4–8 weeks)
• More painful injection
• For pure trigger points (no structural degeneration), efficacy is not necessarily superior to dry needling
Best Indications:
• Chronic low back pain with ligamentous laxity
• Chronic neck pain with facet joint dysfunction
• Chronic post-injury musculotendinous junction pain
• Recurrent injury sites
Therapy C: PRP Injection
Mechanism:
PRP delivers high-concentration growth factors (PDGF, TGF-β, VEGF, IGF-1):
• Stimulates stem cell activation
• Promotes angiogenesis
• Suppresses chronic inflammation
• Accelerates tissue repair
Evidence (2022 RCT):
> Comparing PRP vs dry needling for masseter trigger points: PRP group showed significantly superior pain improvement and patient satisfaction.
Strengths:
• Best long-term outcomes for severe chronic pain
• Autologous-blood source, no foreign-body rejection
• Simultaneously addresses inflammation and promotes repair
• Some studies show effects lasting 6–12 months
Limitations:
• Higher cost
• Slower onset (peak 4–8 weeks)
• Requires autologous blood draw
• Brief swelling at injection site
Best Indications:
• Severe chronic myofascial pain (>6 months)
• Patients with diminishing response to dry needling or medications
• Athletes and high-demand activities
• Budget allowing pursuit of best long-term outcomes
Comprehensive Comparison
Clinical Decision Framework: Which to Choose?
Decision Tree
Step 1: How long has the pain persisted?
• 6 months: consider dextrose prolotherapy or PRP directly
Step 2: Structural degeneration on imaging?
• No structural degeneration, pure myofascial tension: dry needling or PRP
• Structural degeneration (chronic tendon/ligament injury): dextrose prolotherapy or PRP
Step 3: Budget and time
• Budget-limited: start with dry needling
• Moderate budget: dextrose prolotherapy
• Budget allows + best long-term outcome priority: PRP
Stepwise Strategy (Most Common)
Many physicians use "try simple first, upgrade if insufficient":
Month 1: dry needling × 4 sessions
Evaluate: ≥50% improvement → continue maintenance
Key insight: Chronic multifocal myofascial pain often requires a "whole-body treatment strategy" — not just one injection point. Combine with posture correction, strength training, and lifestyle adjustment for the long-term solution.
Common Success Factors
Regardless of injection choice, the following affect success:
Physician Side
Precise trigger point localization: palpation, ultrasound, EMG verification
Correct injection technique: angle, depth, retrograde release
Reasonable protocol design: number, intervals, evaluation points
Integrated treatment plan: injection is one component
Patient Side
Adherence to rehab exercises: moderate activity within 24 hours post-injection
Posture and lifestyle adjustment: remove pain-causing factors
Patience for onset: especially PRP and prolotherapy
Track pain scores: helps physician adjust the plan
Adequate sleep and nutrition: foundation for tissue repair
When to Consider Other Approaches?
Injection therapy is not a panacea. Consider alternative paths if:
• Pain dominated by radiculopathy (e.g., disc herniation compressing nerve) → nerve decompression-related treatment
• Severe postural etiology (scoliosis, pelvic misalignment) → posture therapist required
• High psychological component (depression, chronic stress) → psychological therapy integration
• Pain is inflammatory disease (rheumatoid, ankylosing spondylitis) → rheumatology
Conclusion: "No Best Therapy, Only the Best Fit"
Every chronic pain patient differs in pain nature, cause, and severity. The three injection therapies each have ideal contexts:
• Dry needling: rapid, economical, entry-level
• Dextrose prolotherapy: chronic degeneration, structural laxity
• PRP: severe chronic, long-term outcome priority
Correct selection requires professional evaluation of your specific situation. See our muscle fascia pain regenerative service or book a consultation.
Medical References
Comparative Efficacy of PRP and Dry Needling for Trigger Points in Masseter Muscle: RCT. PubMed PMID: 36445907. 2022.
Dry Needling Versus Trigger Point Injection for Neck Pain: Systematic Review and Meta-Analysis. PubMed PMID: 34114639.
Comparison of dry needling and trigger point injections in TMJ myofascial pain. PMC6797918.
Trigger Point Injection: Background, Indications, Contraindications. Medscape.
Comparison of lidocaine, botulinum toxin, and dry needling to trigger points. Rheumatology International.
Editorial review: Reviewed by Dr. Da-Ru Liu. Last reviewed 2026-04-27.